Drew M. Brown

804 total citations
30 papers, 635 citations indexed

About

Drew M. Brown is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Drew M. Brown has authored 30 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Orthopedics and Sports Medicine, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Drew M. Brown's work include Bone health and osteoporosis research (13 papers), Bone health and treatments (8 papers) and Orthopaedic implants and arthroplasty (6 papers). Drew M. Brown is often cited by papers focused on Bone health and osteoporosis research (13 papers), Bone health and treatments (8 papers) and Orthopaedic implants and arthroplasty (6 papers). Drew M. Brown collaborates with scholars based in United States, Mexico and Spain. Drew M. Brown's co-authors include Matthew R. Allen, Maxime A. Gallant, David B. Burr, Jason M. Organ, Jürgen Roth, A. W. Norman, Lorenzo A. Orci, Joseph M. Wallace, Christopher L. Newman and S. Varadarajan and has published in prestigious journals such as Nature, PLoS ONE and The FASEB Journal.

In The Last Decade

Drew M. Brown

29 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drew M. Brown United States 12 254 225 139 112 87 30 635
Juan J. Haro‐Mora United States 18 64 0.3× 474 2.1× 96 0.7× 95 0.8× 71 0.8× 33 909
Xiang Ao China 14 48 0.2× 157 0.7× 30 0.2× 102 0.9× 84 1.0× 24 500
Senbo An China 14 55 0.2× 214 1.0× 42 0.3× 87 0.8× 10 0.1× 26 585
Osamu Tanaka Japan 13 43 0.2× 232 1.0× 186 1.3× 200 1.8× 31 0.4× 33 932
William G. Mackenzie United States 20 30 0.1× 217 1.0× 51 0.4× 46 0.4× 66 0.8× 25 1.1k
Fashuai Wu China 11 24 0.1× 228 1.0× 81 0.6× 59 0.5× 99 1.1× 23 557
James Anderson United Kingdom 16 23 0.1× 241 1.1× 58 0.4× 247 2.2× 23 0.3× 44 751
Katherine M. Melville United States 11 130 0.5× 239 1.1× 161 1.2× 34 0.3× 41 0.5× 11 616
Natsuko Shimizu Japan 4 43 0.2× 354 1.6× 30 0.2× 154 1.4× 13 0.1× 7 601
Anirudh Sharma Canada 11 42 0.2× 257 1.1× 34 0.2× 180 1.6× 52 0.6× 23 782

Countries citing papers authored by Drew M. Brown

Since Specialization
Citations

This map shows the geographic impact of Drew M. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew M. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew M. Brown more than expected).

Fields of papers citing papers by Drew M. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew M. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew M. Brown. The network helps show where Drew M. Brown may publish in the future.

Co-authorship network of co-authors of Drew M. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Drew M. Brown. A scholar is included among the top collaborators of Drew M. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew M. Brown. Drew M. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gulbronson, Connor J., Peter Jordan, Baskar Ramdas, et al.. (2025). Multiplex imaging of murine bone marrow using Phenocycler 2.0™. Leukemia. 39(6). 1476–1489.
2.
Allen, Matthew R., Erin McNerny, Mohammad W. Aref, et al.. (2017). Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model. PLoS ONE. 12(8). e0181750–e0181750. 5 indexed citations
3.
Aref, Mohammad W., et al.. (2017). Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate. Calcified Tissue International. 101(1). 75–81. 10 indexed citations
4.
Brown, Drew M., et al.. (2017). Rad GTPase is essential for the regulation of bone density and bone marrow adipose tissue in mice. Bone. 103. 270–280. 8 indexed citations
5.
Larsen, Rachel A., Debra L. Hickman, Mohammad W. Aref, et al.. (2017). Effects of daily restraint with and without injections on skeletal properties in C57BL/6NHsd mice. Lab Animal. 46(7). 299–301. 2 indexed citations
6.
Newman, Christopher L., Nannan Tian, Max A. Hammond, et al.. (2016). Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease. American Journal of Nephrology. 43(1). 20–31. 5 indexed citations
7.
Aref, Mohammad W., Erin McNerny, Drew M. Brown, Karl J. Jepsen, & Matthew R. Allen. (2016). Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes. Osteoporosis International. 27(12). 3637–3643. 11 indexed citations
8.
McNerny, Erin, Jason M. Organ, Joseph M. Wallace, et al.. (2016). Assessing the inter- and intra-animal variability of in vivo OsteoProbe skeletal measures in untreated dogs. Bone Reports. 5. 192–198. 5 indexed citations
9.
Maycas, Marta, Kevin McAndrews, Amy Y. Sato, et al.. (2016). PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading. Journal of Bone and Mineral Research. 32(3). 486–497. 45 indexed citations
10.
Srisuwananukorn, Andrew, Matthew R. Allen, Drew M. Brown, Joseph M. Wallace, & Jason M. Organ. (2015). In vivo reference point indentation measurement variability in skeletally mature inbred mice. BoneKEy Reports. 4. 712–712. 6 indexed citations
11.
Newman, Christopher L., Amy Creecy, Mathilde Granke, et al.. (2015). Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease. Kidney International. 89(1). 95–104. 18 indexed citations
12.
Newman, Christopher L., Neal X. Chen, Eric R. Smith, et al.. (2015). Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions. Bone. 77. 50–56. 19 indexed citations
13.
Allen, Matthew R., Christopher L. Newman, Eric R. Smith, Drew M. Brown, & Jason M. Organ. (2014). Variability of in vivo reference point indentation in skeletally mature inbred rats. Journal of Biomechanics. 47(10). 2504–2507. 10 indexed citations
14.
Gallant, Maxime A., Drew M. Brown, Max A. Hammond, et al.. (2014). Bone cell-independent benefits of raloxifene on the skeleton: A novel mechanism for improving bone material properties. Bone. 61. 191–200. 77 indexed citations
15.
Gallant, Kathleen M. Hill, et al.. (2014). Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats. PLoS ONE. 9(9). e108262–e108262. 15 indexed citations
16.
Aref, Mohammad W., Maxime A. Gallant, Jason M. Organ, et al.. (2013). In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6months of treatment in skeletally mature beagle dogs. Bone. 56(2). 449–453. 38 indexed citations
17.
Gallant, Maxime A., Drew M. Brown, Jason M. Organ, Matthew R. Allen, & David B. Burr. (2012). Reference-point indentation correlates with bone toughness assessed using whole-bone traditional mechanical testing. Bone. 53(1). 301–305. 103 indexed citations
18.
Sutton, Richard, et al.. (1990). Reduction of Vinblastine Neurotoxicity in Mice Utilizing a Collagen Matrix Carrier. PubMed. 6(1). 35–49. 11 indexed citations
19.
Brown, Drew M., et al.. (1978). Regulation of 25-hydroxycholecalciferol metabolism by 1,25-dihydroxycholecalciferol in relation to phosphate concentrations [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 79(2). 35P–36P. 1 indexed citations
20.
Brown, Drew M., et al.. (1969). BRL 1288—a New Anti-Parkinson Drug. Nature. 223(5204). 416–417. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan J. Haro‐Mora Breakdown of academic impact, for papers by Xiang Ao Breakdown of academic impact, for papers by Senbo An Breakdown of academic impact, for papers by Osamu Tanaka Breakdown of academic impact, for papers by William G. Mackenzie Breakdown of academic impact, for papers by Fashuai Wu Breakdown of academic impact, for papers by James Anderson Breakdown of academic impact, for papers by Katherine M. Melville Breakdown of academic impact, for papers by Natsuko Shimizu Breakdown of academic impact, for papers by Anirudh Sharma
Rankless by CCL
2026